Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial

Published:2024-07 Issue: Volume:196 Page:110312
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Cooke Saskia A.^ORCID,Belderbos José S.A.,Reymen Bart,Lambrecht Maarten,Fredberg Persson Gitte,Faivre-Finn Corinne,Dieleman Edith M.T.,van Diessen Judi N.A.,Sonke Jan-Jakob,de Ruysscher Dirk

Funder

European Commission Seventh Framework Programme for Research and Technological Development Space

KWF Kankerbestrijding

Publisher

Elsevier BV

Reference31 articles.

1. Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review;Ben;Lung Cancer,2017

2. Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial;Basch;J Clin Oncol,2016

3. 18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial;Cooke;Radiother Oncol,2023

4. The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer;Van Elmpt;Radiother Oncol,2012

5. The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial);van Diessen;Radiother Oncol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP